These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Clinical use of Oka live varicella vaccine. Kamiya H; Sakurai M; Ihara T; Ito M; Torigoe S; Ota Y; Kamiya T; Horiuchi K; Asano Y; Baba K Acta Paediatr Jpn; 1988 Oct; 30(5):594-600. PubMed ID: 2849859 [No Abstract] [Full Text] [Related]
15. Varicella vaccine in children with chronic renal insufficiency. Broyer M; Boudailliez B Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466 [TBL] [Abstract][Full Text] [Related]
16. Live attenuated varicella vaccine use in immunocompromised children and adults. Gershon AA; Steinberg SP; Gelb L Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495 [TBL] [Abstract][Full Text] [Related]
17. Experience with live-attenuated varicella-zoster vaccines. LaRussa P Contrib Microbiol; 1999; 3():173-92. PubMed ID: 10599530 [No Abstract] [Full Text] [Related]
18. Modelling the impact of varicella vaccination on varicella and zoster. Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447 [TBL] [Abstract][Full Text] [Related]
19. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults]. Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935 [TBL] [Abstract][Full Text] [Related]